menu
    • menu

    Company profile for Lidds

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    LIDDS AB (publ) develops injectable drugs for cancer and other diseases based on our unique proprietary NanoZolid® technology. NanoZolid® helps solve some of the main problems with the way drugs work in the body and which affect patient quality of life. NanoZolid® enables the controlled, long-term and personalized release of drugs for up to six months. NanoZolid® can be combined with traditional small molecules as well as ...
    LIDDS AB (publ) develops injectable drugs for cancer and other diseases based on our unique proprietary NanoZolid® technology. NanoZolid® helps solve some of the main problems with the way drugs work in the body and which affect patient quality of life. NanoZolid® enables the controlled, long-term and personalized release of drugs for up to six months. NanoZolid® can be combined with traditional small molecules as well as with larger molecules.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    LiddsSweden Flag
    Country
    Country
    Sweden
    Address
    Address
    Virdings allé 32b, Uppsala, SE-754 50, Sweden
    Telephone
    Telephone
    +46 00 44 55 66
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://liddspharma.com/en/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/12590192/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Report from Extraordinary General Meeting in LIDDS
    Report from Extraordinary General Meeting in LIDDS

    11 Mar 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/03/11/2401744/0/en/Report-from-Extraordinary-General-Meeting-in-LIDDS.html

    GLOBENEWSWIRE
    11 Mar 2022
    Share Share
    LIDDS publishes agenda for the company's Capital Markets Day 2022
    LIDDS publishes agenda for the company's Capital Markets Day 2022

    04 Mar 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/03/04/2397255/0/en/LIDDS-publishes-agenda-for-the-company-s-Capital-Markets-Day-2022.html

    GLOBENEWSWIRE
    04 Mar 2022
    Share Share
    Statement from LIDDS regarding convertible note agreement
    Statement from LIDDS regarding convertible note agreement

    24 Feb 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/02/24/2391009/0/en/Statement-from-LIDDS-regarding-convertible-note-agreement.html

    GLOBENEWSWIRE
    24 Feb 2022
    Share Share
    LIDDS AB (publ) Year-end report 2021
    LIDDS AB (publ) Year-end report 2021

    23 Feb 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/02/23/2390606/0/en/LIDDS-AB-publ-Year-end-report-2021.html

    GLOBENEWSWIRE
    23 Feb 2022
    Share Share
    LIDDS secures financing of 40.8 MSEK to create foundation for new partnerships
    LIDDS secures financing of 40.8 MSEK to create foundation for new partnerships

    22 Feb 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/02/22/2389543/0/en/LIDDS-secures-financing-of-up-to-40-8-MSEK-to-create-foundation-for-new-partnerships-based-on-the-NanoZolid-technology.html

    GLOBENEWSWIRE
    22 Feb 2022
    Share Share
    LIDDS Next Step with NanoZolid formulated docetaxel
    LIDDS Next Step with NanoZolid formulated docetaxel

    21 Feb 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/02/21/2388723/0/en/LIDDS-Next-Step-with-NanoZolid-formulated-docetaxel.html

    GLOBENEWSWIRE
    21 Feb 2022
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search